We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
-4.97%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$2.49B
AUM Growth
+$90.9M
Cap. Flow
+$292M
Cap. Flow %
11.71%
Top 10 Hldgs %
51.5%
Holding
51
New
9
Increased
22
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$90.1M
2
GILD icon
Gilead Sciences
GILD
+$67.3M
3
WFC icon
Wells Fargo
WFC
+$59.4M
4
FRO icon
Frontline
FRO
+$48M
5
NOC icon
Northrop Grumman
NOC
+$46.9M

Top Sells

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$99.5M
2
TCOM icon
Trip.com Group
TCOM
+$46.2M
3
SONO icon
Sonos
SONO
+$41M
4
PATH icon
UiPath
PATH
+$37M
5
BEKE icon
KE Holdings
BEKE
+$35.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Communication Services 15.51%
3 Technology 14.6%
4 Consumer Discretionary 10.69%
5 Materials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCOM icon
26
Trip.com Group
TCOM
$29.3B
$42.1M 1.69%
1,539,825
-1,763,882
-53% -$46.2M
COMP icon
27
Compass
COMP
$8.56B
$33.9M 1.36%
14,618,545
+1,839,098
+14% +$6.53M
LOW icon
28
Lowe's Companies
LOW
$118B
$32.7M 1.31%
+174,297
New +$33.9M
COR icon
29
Cencora
COR
$60.7B
$30.3M 1.21%
223,590
+132,520
+146% +$19M
ROKU icon
30
Roku
ROKU
$21.5B
$29.8M 1.19%
527,825
-123,085
-19% -$9.37M
BEKE icon
31
KE Holdings
BEKE
$18.8B
$27.5M 1.1%
1,571,359
-2,192,984
-58% -$35.5M
FLS icon
32
Flowserve
FLS
$9.63B
$26.6M 1.07%
1,096,028
-158,945
-13% -$4.81M
LYFT icon
33
Lyft
LYFT
$5.9B
$21.8M 0.87%
+1,653,282
New +$25.4M
BIDU icon
34
Baidu
BIDU
$36.5B
$18M 0.72%
153,554
-214,670
-58% -$29.3M
BAH icon
35
Booz Allen Hamilton
BAH
$8.22B
$17.9M 0.72%
+193,300
New +$18.3M
IBN icon
36
ICICI Bank
IBN
$109B
$3.71M 0.15%
176,682
+104,948
+146% +$2.22M
TMO icon
37
Thermo Fisher Scientific
TMO
$214B
$2.73M 0.11%
+5,381
New +$3.01M
LMT icon
38
Lockheed Martin
LMT
$132B
$1.25M 0.05%
3,236
+706
+28% +$295K
JD icon
39
JD.com
JD
$43.6B
$850K 0.03%
16,902
-219
-1% -$13K
HTHT icon
40
Huazhu Hotels Group
HTHT
$13B
$480K 0.02%
14,326
+5,127
+56% +$194K
MELI icon
41
Mercado Libre
MELI
$95.6B
$477K 0.02%
577
+509
+749% +$437K
WNS
42
DELISTED
WNS Holdings
WNS
$261K 0.01%
3,195
-271
-8% -$22.5K
FMX icon
43
Fomento Económico Mexicano
FMX
$43.2B
$242K 0.01%
+3,866
New +$244K
PBR icon
44
Petrobras
PBR
$123B
$195K 0.01%
+15,876
New +$210K
API
45
Agora
API
$337M
-63,072
Closed -$414K
CTRA
46
DELISTED
Coterra Energy
CTRA
-3,857,681
Closed -$99.5M
GDS icon
47
GDS Holdings
GDS
$6.41B
-527,934
Closed -$17.6M
GE icon
48
GE Aerospace
GE
$368B
-376,584
Closed -$14.9M
PATH icon
49
UiPath
PATH
$6.41B
-2,035,023
Closed -$37M
QRVO icon
50
Qorvo
QRVO
$8.01B
-160,588
Closed -$15.1M

Similar funds

Antipodes Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Antipodes Partners held 51 positions worth $2.49B, up 3.8% from $2.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Antipodes Partners deployed $292M of net new capital in Q3 2022, opening 9 new positions and adding to 22 existing holdings. Its largest new stake was Capital One: 846,090 shares worth $78M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Trip.com Group, an estimated $46.2M trimmed.

  • Antipodes Partners's largest Q3 2022 buy was Capital One: 846,090 shares worth $78M.
  • Antipodes Partners added most to Wells Fargo in Q3 2022, an estimated $59.4M increase.
  • Antipodes Partners's biggest Q3 2022 reduction was Trip.com Group, cutting an estimated $46.2M.
  • Antipodes Partners fully exited Coterra Energy in Q3 2022, selling an estimated $99.5M.
  • Antipodes Partners's ten largest holdings make up 51% of its $2.49B portfolio in Q3 2022.
  • Antipodes Partners opened 9 new positions and closed 7 in Q3 2022.
  • Antipodes Partners's portfolio value rose 3.8% quarter-over-quarter to $2.49B.

Based on Antipodes Partners's 13F filing for Q3 2022, filed 10 Nov 2022.